Christopher Bowden, Chief Medical Officer at AGIOS PHARMACEUTICALS INC (AGIO), sold 2,700 shares at $84.78 ($230K) on 2018-04-12, disclosed to the SEC on 2018-04-16.
Open-market sale of $230k AGIO by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $84.78 | 1,300 | $110K | 47.9% |
| 2 | $85.68 | 700 | $60K | 26.1% |
| 3 | $85.68 | 700 | $60K | 26.1% |
| Total | $85.25 avg | 2,700 | $230K | 100% |
| Filing → |
| AGIO | SELL | 2021-06-11 | $3.4M | — | Filing → |
| AGIO | SELL | 2021-06-09 | $1.3M | — | Filing → |
| AGIO | SELL | 2021-04-21 | $1.9M | — | Filing → |